| Date Filed | Type | Description |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/24/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/21/2023 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 360 shares
@ $294.52, valued at
$106k
Sold 784 shares
@ $295.43, valued at
$231.6k
Sold 240 shares
@ $296.3, valued at
$71.1k
Sold 360 shares
@ $298.09, valued at
$107.3k
Sold 240 shares
@ $299.58, valued at
$71.9k
Sold 16 shares
@ $301.13, valued at
$4.8k
|
|
| 03/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/14/2023 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 361 shares
@ $286.64, valued at
$103.5k
Sold 515 shares
@ $287.83, valued at
$148.2k
Sold 327 shares
@ $288.91, valued at
$94.5k
Sold 30 shares
@ $289.44, valued at
$8.7k
Sold 541 shares
@ $291.47, valued at
$157.7k
Sold 185 shares
@ $292.68, valued at
$54.1k
Sold 27 shares
@ $293.61, valued at
$7.9k
Sold 102 shares
@ $294.94, valued at
$30.1k
Sold 24 shares
@ $288.31, valued at
$6.9k
Sold 420 shares
@ $292.41, valued at
$122.8k
Sold 1,153 shares
@ $293.35, valued at
$338.2k
|
|
| 03/13/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 03/10/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,308 shares
@ $289.12, valued at
$956.4k
|
|
| 02/22/2023 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,750 shares
@ $292.85, valued at
$1.1M
|
|
| 02/14/2023 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 2,707 shares
@ $294.33, valued at
$796.8k
Paid exercise price by delivering 4,992 shares
@ $298.26, valued at
$1.5M
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 300 shares
@ $261.42, valued at
$78.4k
Sold 381 shares
@ $263.67, valued at
$100.5k
Sold 1,142 shares
@ $265.06, valued at
$302.7k
Sold 536 shares
@ $265.95, valued at
$142.5k
Sold 223 shares
@ $266.68, valued at
$59.5k
|
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2020 |
4
| WAGNER CHARLES F JR (EVP and CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 547 shares
@ $251.78, valued at
$137.7k
|
|
| 02/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2020 |
4
| WAGNER CHARLES F JR (EVP and CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 3,698 shares
@ $0
Granted 10,323 shares
@ $0 |
|
| 04/12/2019 |
4
| WAGNER CHARLES F JR (EVP and CFO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Granted 3,697 shares
@ $0
Granted 9,532 options to buy
@ $189.38, valued at
$1.8M
|
|
| 04/12/2019 |
3
| WAGNER CHARLES F JR (EVP and CFO) has filed a Form 3 on VERTEX PHARMACEUTICALS INC / MA |
| 03/18/2015 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on BRUKER CORP|
Txns:
| Sold 19,000 shares
@ $18.9733, valued at
$360.5k
|
|
| 09/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/12/2014 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 25,895 shares
@ $0
Granted 49,400 options to buy
@ $20.68, valued at
$1M
|
|
| 08/05/2014 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on BRUKER CORP|
Txns:
| Paid exercise price by delivering 10,476 shares
@ $22.4, valued at
$234.7k
|
|
| 09/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/15/2012 |
4
| WAGNER CHARLES F JR (EVP & CFO) has filed a Form 4 on BRUKER CORP|
Txns:
| Granted 5,000 options to buy
@ $12.06, valued at
$60.3k
|
|
|